RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 NS104022
National Institutes of Health
Grant: R35 GM131839
National Institutes of Health
Grant: S10 OD020012
National Institute of Neurological Disorders and Stroke
Grant: R01 NS111990
National Institute of Neurological Disorders and Stroke
Grant: DP2 OD027719-01
National Institute of Neurological Disorders and Stroke
Grant: NS131756
National Institute of Neurological Disorders and Stroke
Grant: NR020231
National Institute of Neurological Disorders and Stroke
Grant: U24NS113844
NIAID NIH HHS
Grant: T32 AI095213
NINDS NIH HHS
Grant: R21 NS131756
Target ALS
Rita Allen Foundation
ALS Association
Richard and Susan Smith Family Foundation
ALS Hope Foundation
FWCI
5.64
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals